In COVID-19 clinical update #88, Dr. Griffin covers vaccine protection among US veterans, absence of long COVID in vaccinated who are infected, single dose of REGEN-COV monoclonal antibody cocktail provides long term protection, and Pfizer protease inhibitor Paxlovid is 89% effective in preventing hospitalization or death.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

Vaccine protection of US veterans (Science)
Long term protection by REGEN-COV (Regeneron)
Pfizer protease inhibitor Paxlovid phase 2/3 results (Pfizer)
Letters read on TWiV 828
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

TWiV 828: COVID-19 clinical update #88 with Dr. Daniel Griffin